EX-10.1


 Exhibit 10.1 

SECOND SUPPLEMENTAL INDENTURE 

Second Supplemental Indenture, dated as of August 7, 2017 (this “Second Supplemental Indenture”), among INC Research
Holdings, Inc., a Delaware corporation (“INC”), inVentiv Health, Inc., a Delaware corporation (“inVentiv Health”), inVentiv Health Clinical, Inc., a Delaware corporation (“inVentiv
Clinical”), the guarantors named in the signature pages hereto as New Guarantors (the “New Guarantors”), the guarantors named in the signature pages hereto as Existing Guarantors (the “Existing Guarantors”
and together with the New Guarantors, the “Guarantors”) and Wilmington Trust, National Association, as trustee (the “Trustee”). 

W I T N E S S E T H: 

WHEREAS, Double Eagle Acquisition Sub, Inc. and the Trustee have heretofore executed and delivered an indenture, dated as of October 14,
2016 (the “Base Indenture”), as previously supplemented by the First Supplemental Indenture, dated as of November 9, 2016 (together with the Base Indenture, the “Indenture”), among inVentiv Group Holdings, Inc.
(the “Company”), inVentiv Health, inVentiv Clinical, the guarantors party thereto and the Trustee, providing for the issuance of 7.500% Senior Notes due 2024 (the “Notes”); 

WHEREAS, the Company desires to merge with and into INC with INC to be the surviving entity of such merger (the “Merger”);

 WHEREAS, after the Merger is consummated, INC will become the Successor Company and the Company will cease to exist; 

WHEREAS, Section 4.1 of the Indenture provides that under certain circumstances the Company may consolidate or merge with or into a
Successor Company provided that, the Successor Company expressly assumes, by supplemental indenture, executed and delivered to the Trustee, all of the Company’s obligations under the Notes and the Indenture; 

WHEREAS, the Company desires that INC assume the Company’s obligations under the Notes and the Indenture, and INC desires to assume the
Company’s obligations under the Notes and the Indenture; 
 WHEREAS, Section 3.7 of the Indenture provides that under certain
circumstances a Restricted Subsidiary is required to deliver a supplemental indenture to the Indenture providing for a Guarantee by such Restricted Subsidiary; 

WHEREAS, the New Guarantors, which are Wholly-Owned Domestic Subsidiaries that are Restricted Subsidiaries, desire to Guarantee the Notes;

 WHEREAS, pursuant to Section 9.1 of the Indenture, the Trustee, INC, inVentiv Health, inVentiv Clinical and the Guarantors are
authorized to execute and deliver this Second Supplemental Indenture to amend or supplement the Indenture, without notice to or consent of any Holder. 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged,
the Trustee, INC, inVentiv Health, inVentiv Clinical and the Guarantors mutually covenant and agree for the equal and ratable benefit of the Holders as follows: 






 ARTICLE I 

Definitions 

Section 1.1 Defined Terms. As used in this Second Supplemental Indenture, terms defined in the Indenture or in the preamble or
recitals hereto are used herein as therein defined. The words “herein,” “hereof” and “hereby” and other words of similar import used in this Second Supplemental Indenture refer to this Second Supplemental Indenture as a
whole and not to any particular section hereof. 
 ARTICLE II 

Assumption of the Obligations 

Section 2.1. Assumption of Obligations. INC, as the Successor Company, hereby assumes, subject to and effective upon the effective
time of the Merger, all of the Company’s obligations under the Notes and the Indenture. In accordance with Section 4.1 of the Indenture, INC shall, subject to and effective upon the effective time of the Merger, succeed to, and shall be
substituted for, and may exercise every right and power of, the Company under the Notes and the Indenture. INC shall give written notice (which may be by e-mail) to the Trustee of the occurrence of the
effective time of the Merger. 
 Section 2.2. Benefits Acknowledged. INC acknowledges that it will receive direct and indirect
benefits from the financing arrangements contemplated by the Indenture and this Second Supplemental Indenture and that the assumption of all of the Company’s obligations under the Notes and the Indenture is knowingly made in contemplation of
such benefits. 
 ARTICLE III 

Agreement to be Bound; Guarantee 

Section 3.1. Agreement to be Bound. Each New Guarantor hereby becomes a party to the Indenture as a Guarantor and as such will
have all of the rights and be subject to all of the obligations and agreements of a Guarantor under the Indenture. 
 Section 3.2.
Guarantee. Each New Guarantor agrees, on a joint and several basis with all the other Guarantors, to fully, unconditionally and irrevocably Guarantee to each Holder of the Notes and the Trustee the Guaranteed Obligations pursuant to Article X
of the Indenture on a senior basis. The Guarantee provided by each New Guarantor shall be released in accordance with Section 10.2 of the Indenture. 

Section 3.3. Benefits Acknowledged. Each New Guarantor’s Guarantee is subject to the terms and conditions set forth in the
Indenture. Each New Guarantor acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by the Indenture and this Second Supplemental Indenture and that the Guarantee made by it pursuant to this
Second Supplemental Indenture is knowingly made in contemplation of such benefits. 






 Section 3.4. Execution and Delivery. Each New Guarantor agrees that its Guarantee
shall remain in full force and effect notwithstanding any failure to endorse on each Note a notation of any such Guarantee. 
 ARTICLE IV

 Miscellaneous 

Section 4.1. Notices. All notices and other communications to INC, inVentiv Health, inVentiv Clinical and the Guarantors shall be
given as provided in the Indenture, at the address set forth below 
 INC Research Holdings, Inc. 

3201 Beechleaf Court, Suite 600 

Raleigh, NC 27604 
 Attention:
Chief Financial Officer 
 Email: gregory.rush@incresearch.com 

Facsimile: (919) 334-3651 

Section 4.2. Parties. Nothing expressed or mentioned herein is intended or shall be construed to give any Person, firm or
corporation, other than the Holders and the Trustee, any legal or equitable right, remedy or claim under or in respect of this Second Supplemental Indenture or the Indenture or any provision herein or therein contained. 

Section 4.3. Governing Law. This Second Supplemental Indenture shall be governed by, and construed in accordance with, the laws of
the State of New York. 
 Section 4.4. Severability. In case any provision in this Second Supplemental Indenture shall be
invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective only to the extent of such invalidity, illegality
or unenforceability. 
 Section 4.5. Ratification of Indenture; Supplemental Indentures Part of Indenture. Except as expressly
amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Second Supplemental Indenture shall form a part of the Indenture for all
purposes, and every Holder heretofore or hereafter authenticated and delivered shall be bound hereby. 
 Section 4.6. The
Trustee. The Trustee makes no representation or warranty as to the validity or sufficiency of this Second Supplemental Indenture or with respect to the recitals contained herein, all of which recitals are made solely by the other parties hereto.

 Section 4.7. Counterparts. The parties hereto may sign any number of copies of this Second Supplemental Indenture. Each
signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of this Second Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and
delivery of this Second Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their
original signatures for all purposes. 






 Section 4.8. Headings. The headings of the Articles and the Sections in this Second
Supplemental Indenture are for convenience of reference only and shall not be deemed to alter or affect the meaning or interpretation of any provisions hereof. 

Section 4.9. Successors. All agreements of INC, inVentiv Health, inVentiv Clinical and the Guarantors in this Second Supplemental
Indenture shall bind their successors, except as otherwise provided in this Second Supplemental Indenture. All agreements of the Trustee in this Second Supplemental Indenture shall bind its successors. 






 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed as of the date first above written. 
  

					
	 INC RESEARCH HOLDINGS, INC.
 as
Successor Company

		
		 	 /s/ Christopher L. Gaenzle

		 	Name:	 	Christopher L. Gaenzle
		 	Title:	 	 General Counsel and Corporate

Secretary



  

					
	 INVENTIV HEALTH, INC.
 as Co-Issuer

		
	By:	 	 /s/ Brandon Eldredge

		 	Name:	 	Brandon Eldredge
		 	Title:	 	Senior Vice President & Treasurer


  

					
	 INVENTIV HEALTH CLINICAL, INC.
 as Co-Issuer

		
	By:	 	 /s/ Brandon Eldredge

		 	Name:	 	Brandon Eldredge
		 	Title:	 	Senior Vice President & Treasurer


 [Signature Page to Second Supplemental Indenture] 






 
					
	 ADDISON WHITNEY LLC
 ADHERIS,
LLC
 ALLIDURA COMMUNICATIONS, LLC
 BIOSECTOR 2 LLC

BLUE DIESEL, LLC
 CADENT MEDICAL COMMUNICATIONS, LLC

CHAMBERLAIN COMMUNICATIONS GROUP LLC
 CHANDLER CHICCO AGENCY,
L.L.C.
 GERBIG, SNELL/WEISHEIMER ADVERTISING, LLC
 INCHORD
HOLDING CORPORATION
 INVENTIV CLINICAL, LLC
 INVENTIV
COMMERCIAL SERVICES, LLC
 INVENTIV HEALTH COMMUNICATIONS, INC.

INVENTIV DIGITAL + INNOVATION, LLC
 INVENTIV HEALTH CLINICAL LAB,
INC.
 INVENTIV HEALTH CLINICAL RESEARCH SERVICES, LLC
 INVENTIV
HEALTH CLINICAL SRE, LLC
 INVENTIV HEALTH CLINICAL, LLC

INVENTIV HEALTH CONSULTING, INC.
 INVENTIV HEALTH PUBLIC
RELATIONS, LLC
 INVENTIV HEALTH RESEARCH & INSIGHTS, LLC

INVENTIV MEDICAL COMMUNICATIONS, LLC
 LITMUS MEDICAL MARKETING
SERVICES LLC
 NAVICOR GROUP, LLC
 PALIO + IGNITE, LLC

PATIENT MARKETING GROUP, LLC
 PHARMA HOLDINGS, INC.

PHARMACEUTICAL INSTITUTE, LLC
 SOUTH FLORIDA KINETICS, INC.

THE SELVA GROUP, LLC,
 as Existing Guarantors

		
	By:	 	 /s/ Brandon Eldredge

		 	Name:	 	Brandon Eldredge
		 	Title:	 	Senior Vice President & Treasurer


 [Signature Page to Second Supplemental Indenture] 






 
					
	 INC RESEARCH, LLC
 as a New
Guarantor

		
	By:	 	 /s/ Christopher L. Gaenzle

		 	Name:	 	Christopher L. Gaenzle
		 	 Title:
	 	 General Counsel and Corporate

Secretary



  

					
	 KENKKENDLE AMERICAS MANAGEMENT INC.

as a New Guarantor

		
	By:	 	 /s/ Christopher L.
Gaenzle



 
					
		 	Name:	 	Christopher L. Gaenzle
		 	Title:	 	General Counsel and Corporate Secretary


  

					
	 KEKEKENDLE AMERICAS INVESTMENT INC.

as a New Guarantor

		
	By:	 	 /s/ Christopher L. Gaenzle

		 	Name:	 	Christopher L. Gaenzle
		 	Title:	 	General Counsel and Corporate Secretary


 [Signature Page to Second Supplemental Indenture] 






 
			
	 WILMINGTON TRUST, NATIONAL ASSOCIATION

as Trustee

		
	By:	 	 /s/ Lynn M. Steiner

	Name:	 	Lynn M. Steiner
	Title:	 	Vice President


 [Signature Page to Second Supplemental Indenture]